secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001193125-25-022711
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 5.08
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio receives Nasdaq bid-price extension to Aug 4, 2025; stock moves to Capital Market
--------------------------------------------------------------------------------

- Nasdaq granted IN8bio until Aug 4, 2025 to achieve $1.00 closing bid for 10 consecutive days.
- Common stock transferred from Nasdaq Global Market to Nasdaq Capital Market effective Feb 7, 2025.
- Company may consider reverse stock split to regain compliance if needed.
- 2025 Annual Meeting set for May 8; record date March 12, 2025.
- Stockholder proposals and director nominations due Feb 17, 2025; universal proxy notice due March 9.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525022711/0001193125-25-022711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525022711/d841361d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-022711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer